Cite
A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform
MLA
Júlia Vergara-Alert, et al. A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform. Nov. 2015. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d1b833aba35497ca87d7f665cdb0a9c4&authtype=sso&custid=ns315887.
APA
Júlia Vergara-Alert, Dorothea Kreuz, Stephan Becker, Anna H. Malczyk, Steffen Prüfer, Ugur Sahin, Tim Beissert, Stefanie Hubich-Rau, Klaus Cichutek, Yasemin Süzer, Alexandra Kupke, Christiane Tondera, Kay-Martin Hanschmann, Susanne Herold, Ulrich Kalinke, Stefan Hutzler, Vivian A. Scheuplein, Janna Seifried, Zoe Waibler, … Stefanie Bauer. (2015). A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform.
Chicago
Júlia Vergara-Alert, Dorothea Kreuz, Stephan Becker, Anna H. Malczyk, Steffen Prüfer, Ugur Sahin, Tim Beissert, et al. 2015. “A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform,” November. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d1b833aba35497ca87d7f665cdb0a9c4&authtype=sso&custid=ns315887.